Psychedelic Conference Draws Scientists, Biohackers and Mainstream Enthusiasts to Austin
Around 600 attendees gathered in Austin for a three-day event showcasing psychedelics as potential mental-health tools, featuring researchers, investors and everyday wellness seekers.
In Austin, Texas, the inaugural Beyond Psychedelics Conference brought together roughly 600 people ranging from academic researchers to biohacking enthusiasts and ordinary wellness seekers. Organized by Dave Asprey, the event featured talks on the latest scientific studies at places like Johns Hopkins and Mount Sinai, as well as panels on investment trends and evolving legal frameworks. Attendees could sample psilocybin-laden chocolates, designer psychoactive capsules, and services that connect users with vetted therapists and retreat centers.
Non-pharmacological experiences such as intensive breathwork and neurofeedback were also offered. Clinicians like David Rabin emphasized that drugs such as ketamine show promise only when combined with psychotherapy, and warned against unsupervised use. While enthusiasm grew, speakers stressed the need for careful clinical protocols to manage potential psychological and cardiovascular risks.
Why it matters
The event signals growing mainstream interest and investment in psychedelics as possible treatments for mental-health disorders.
In this story
